New hope for kids with arthritis: Long-Term drug study launches
NCT ID NCT07553182
First seen May 07, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study looks at the long-term safety and effectiveness of the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA). Participants must have already completed a previous filgotinib study and shown improvement. The goal is to see if the drug continues to control disease symptoms over time and to monitor any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asklepios Klinik Sankt Augustin GmbH
NOT_YET_RECRUITINGSankt Augustin, 53757, Germany
Contact
-
Bicetre Hospital
NOT_YET_RECRUITINGLe Kremlin-Bicêtre, 94270, France
Contact
-
Great Ormond Street Hospital for Children
NOT_YET_RECRUITINGLondon, WC1N 3JH, United Kingdom
Contact
-
Hamburger Zentrum für Kinder- und Jugendrheumatologie
RECRUITINGHamburg, 22081, Germany
Contact
Conditions
Explore the condition pages connected to this study.